CNN Reports President Obama Declares National Emergency To Deal With The "Rapid Increase In Illness" From The H1N1 Influenza Virus; Cannabis Science Continues Progress On Its Research To Show Cannabis Can Reduce Risk of Death from "Swine Flu"

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is urging that US government recognize that phytocannabinoid pharmaceutical products can help reduce Adult Respiratory Distress Syndrome (ARDS)-associated deaths from both the Avian and Swine Influenza infections, as President Obama declares a national emergency. President Obama signed the declaration late Friday and announced it Saturday. We urge readers go to: http://www.cnn.com/2009/HEALTH/10/24/h1n1.obama/index.html to read the whole story on the CNN website.

President Obama stated, "The 2009 H1N1 pandemic continues to evolve. The rates of illness continue to rise rapidly within many communities across the nation, and the potential exists for the pandemic to overburden health care resources in some localities."

President Obama continued with, "Thus, in recognition of the continuing progression of the pandemic, and in further preparation as a nation, we are taking additional steps to facilitate our response."

Cannabis Science, Inc. President & CEO Dr. Robert Melamede stated, "Clearly, there is little time to gear up the mass production of pharmaceutical cannabis products to meet the immediate needs of this national emergency. However, President Obama's new policy of federal tolerance of medical marijuana where is it legal under state laws, makes it possible for Cannabis Science to work with the medical marijuana patients and providers in some states to help develop products to meet patients' needs. If the situation is dire enough to justify calling it a 'National Emergency', then surely medical ethics require that we work diligently with all relevant research."

Dr. Melamede also deplored efforts in Los Angeles and other areas to close dispensaries and/or ban edibles. "It is hard to imagine a more wrong-headed approach or a worse time to deprive people of access to cannabis edibles. Again, we recommend, based on sound scientific principles, that medical marijuana users should switch to edibles if they come down with an influenza infection. We believe that the irritation associated with the pulmonary route, when a person has an influenza infection, may lead to unnecessary deaths. In contrast, oral administration may prevent many deaths. We hope that due to the magnitude of this pandemic threat, that the FDA will fast track our proposal."

Please visit our website www.cannabisscience.com in the next few days as we will be posting a survey for those who encountered the H1N1 and other influenza symptoms and experiences. This Cannabis Science Survey will be designed to acquire anecdotal human data regarding the effects of Medical Marijuana on influenza infections. The company plans to monitor activity, collect data, and report findings in its reports to the FDA.

Cannabis Science H1N1 Swine Flu Formulation:

Dr. Melamede explains, "We now know that the endocannabinoid system plays a critical role in maintaining human health. The human body produces Endocannabinoids on demand when they are needed. They help restore homeostasis (biochemical balance). The Cannabis plant produces Phytocannabinoids. When the human body has endocannabinoid deficiencies, it cannot effectively restore the healthy biochemical state needed to counter a particular illness. Phytocannabinoids from the Cannabis plant can replace the deficient endocannabinoid activity in the human body to restore a health-promoting level of cannabinoid activity. Cannabis Science will test its pharmaceutical products with FDA guidance and oversight to determine if it will reduce ARDS-associated deaths from both the Avian and Swine influenza infections."

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.